European Journal of Pharmaceutical Sciences

Article	Citations
Integrated models of population pharmacokinetics and exposure response to optimize dosage regimen for anaprazole sodium in duodenal ulcer	228
Biophysical and permeability characterization of lyophilized (freeze-dried) human cadaver skin	198
Editorial Board	186
Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases	158
CYP2E1 mediated advanced oxidation protein products exacerbate acetaminophen induced drug-derived liver injury in vitro and in vivo	137
Impact of therapeutic drug monitoring on microbiological eradication in patients with staphylococcus aureus bacteremia	126
Esomeprazole prevents oxaliplatin-induced peripheral neuropathy through inhibiting organic cation transporter 2 in mice	126
Natural borneol serves as an adjuvant agent to promote the cellular uptake of piperlongumine for improving its antiglioma efficacy	112
The effect of formulation composition and flow conditions on the robustness of semisolid extrusion 3D printing: a case study on poorly water-soluble itraconazole for oral dosage form production	96
VA1213, a selective COX-2 inhibitor, exhibits antitumor activity by suppressing EGFR, AKT, and ERK1/2 phosphorylation	77
Evaluating rat and canine microbiota models for predicting human colonic prodrug metabolism	69
Application of a forward design-based multi-attribute decision-making method in quality assessment in pharmaceutical tablet manufacturing	65
Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets	59
Evaluating the influence of the initial high molecular weight level on monoclonal antibody particle formation kinetics using a short-term chemical stress study	58
3D printed extended-release hydrochlorothiazide tablets	58
Surrogate-based LC–MS/MS quantification of endogenous creatinine in plasma, plasma-equivalent dried spots (qDPS), and volumetric absorptive microsampling (VAMS): an ICH M10-compliant bridging study	56
Epigenetic therapeutics attenuate kidney injury and fibrosis by restoring the expression of epigenetically reprogrammed fibrogenic genes and signaling pathways	53
Development of Imiquimod-induced HaCaT-THP-1 co-culture for modeling of psoriasis	53
In Vitro Investigation of Tapinarof-Loaded Nanogels in an Imiquimod-induced HaCaT–THP-1 Co-Culture Model	53
Probing O-substituted nifuroxazide analogues against Leishmania: Synthesis, in vitro efficacy, and hit/lead identification	51
Development and optimization of Soluplus®/Pluronic-based polymeric micelles for bicalutamide delivery: characterization, lyophilization, stability, and cellular studies	49
Exposure–response modeling of QTc interval and creatine kinase-MB in healthy people and treatment-naïve adults living with HIV-1 treated with ainuovirine monotherapy or combined with lamivudine and te	46
Opportunities of topical drug products in a changing dermatological landscape	46
Effect of process parameters in high shear granulation on characteristics of a novel co-processed mesoporous silica material	46
Nitrite testing in excipients – Industry best practices	44

Intranasal propranolol hydrochloride-loaded PLGA-lipid hybrid nanoparticles for brain targeting: Optimization and biodistribution study by radiobiological evaluation	44
In vitro identification of decreased function genetic variants of ABCB1	43
Development of a new inhaled swellable microsphere system for the dual delivery of naringenin-loaded solid lipid nanoparticles and doxofylline for the treatment of asthma	41
Impact of protein adsorption during biopharmaceutical manufacture & storage	41
Development of a thermosensitive hydrogel based on Polaxamer 407 and gellan gum with inclusion complexes (Sulfobutylated-β-cyclodextrin–Farnesol) as a local drug delivery system	40
FOSL1 mediates collagen synthesis and myofibroblast transformation in aortic fibroblasts under Ang II-induced aortic dissection conditions	40
Soft mist inhaler nebulization by Rayleigh-breakup largely preserves functional integrity of liposomal mRNA in respirable aerosols	39
Triplet Radio-Chemo-Immunotherapy Reprograms the PD-L1–CDK6 Axis to Remodel the Tumor Microenvironment and Overcome Immune Resistance in Head and Neck Cancer	38
Microparticles and multi-unit systems for advanced drug delivery	38
Virtual special issue of Nordic POP: Patient-oriented products	37
Dose finding for ZSP1601 in patients with nonalcoholic steatohepatitis using population pharmacokinetics and exposure–response approach	37
Towards optimization of dexamethasone therapy in the maintenance phase of pediatric acute lymphoblastic leukemia: A population pharmacokinetic and pharmacodynamic study of dexamethasone and metabolite	37
Corrigendum to “iRGD-modified peptide–drug conjugate improves brain delivery and antitumor efficacy in glioblastoma” [European Journal of Pharmaceutical Sciences 224 (2026) 107599]	37
In Vitro and In Vivo Evaluation of Dark Chocolate as Age-appropriate Oral Matrix	36
Bicarbonate buffer dissolution test with gentle mechanistic stress for bioequivalence prediction of enteric-coated pellet formulations	35
Low-dose apatinib in subjects with renal impairment: A pharmacokinetics study	34
Role of exosomes in bone and joint disease metabolism, diagnosis, and therapy	34
Editorial Board	34
Population pharmacokinetics of posaconazole in Chinese pediatric patients with acute leukaemia: Effect of food on bioavailability and dose optimization	34
Preclinical characterization of a novel potent core protein assembly modulator for the treatment of chronic hepatitis B viral infection	33
Optimization, characterization and in vivo evaluation of mupirocin nanocrystals for topical administration	33
Stability evaluation from hydrogen peroxide spiking studies	33
Pharmacokinetic and bioequivalence study of two capecitabine tablets in Chinese patients with breast, colorectal or gastric cancer under fed condition: A multicentric, randomized, open-label, single-d	33
Pharmacological countermeasures for long-duration space missions: addressing cardiovascular challenges and advancing space-adapted healthcare	33
In vitro inhibition of organic anion transporting polypeptide 2B1 (OATP2B1) is common among marketed drugs	32
Viva la pharmacie – Spotlight on pharmaceutical manufacturing science	32
Exploring Kp,uu,BBB values smaller than unity in remoxipride: A physiologically-based CNS model approach highlighting brain metabolism in drugs with passive blood-brain barrier transport	31
Direct comparison of single peak and gradient chromatographic methods for routine analysis of surfactants in biopharmaceuticals	31
Uncertainties in drug dissolution tests - identification and CFD evaluation of factors limiting the accuracy of the USP2 test	31
Exploration of solubilisation effects facilitated by the combination of Soluplus® with ionic surfactants	31
Synthesis and physicochemical characterization of new potential haptens and their precursors with morphine skeleton	31
Erratum to “The fourth-generation EGFR tyrosine kinase inhibitor BLU-945 resensitizes ABCG2-overexpressing multidrug-resistant non-small cell lung cancer cells to cytotoxic anticancer drugs” [European	31
Minimizing aggregates when nebulizing antibody Fab fragments: high thermostability and high concentration are key	31
Corrigendum to “Physiologically-based pharmacokinetic modeling of natalizumab for multiple sclerosis patients to predict the withdrawal time in pregnancy and vaccine time in infants” [European Journal	31
Population pharmacokinetics of mycophenolic acid and Bayesian estimator in lung transplant adults recipients in the early post-transplant period	31
Mucoadhesive in situ nasal gel of amoxicillin trihydrate for improved local delivery: Ex vivo mucosal permeation and retention studies	29
TLD: An optimized liposomal doxorubicin formulation with small vesicle size for improved anti-tumor efficacy	29
Effect of different seed crystals on the supersaturation state of ritonavir tablets prepared by hot-melt extrusion	28
High cancer selectivity and improving drug release from mesoporous silica nanoparticles in the presence of human serum albumin in cisplatin, carboplatin, oxaliplatin, and oxalipalladium treatment	28
iRGD mediated pH-responsive mesoporous silica enhances drug accumulation in tumors	27
Controlled release and extended pulmonary retention of inhaled therapeutics: A review	27
Advanced interpenetrating polymer networks for innovative gastroretentive formulations targeting Helicobacter pylori gastric colonization	27
Cocrystal mitigates the effects of elevated gastric pH on oral absorption of weakly basic drugs: a case study with ketoconazole-succinic acid cocrystal on beagle dogs	27
Scaling up controlled nucleation in freeze drying: Translating vacuum-induced surface freezing from laboratory to GMP	27
Optimizing post-printing drying conditions for point-of-care manufacturing of SSE-3D printed medicines	27
RNA-Seq transcriptome analysis of renal tissue from spontaneously hypertensive rats revealed renal protective effects of dapagliflozin, an inhibitor of sodium-glucose cotransporter 2	26
Locally acting dermatology drug products: Pharmaco-analytic considerations for bioequivalence	26
Long-acting intramuscular injections of ELQ-331, an antimalarial agent	26
Do Chinese HIV-infected adult patients with altered renal function need to adjust tenofovir disoproxil fumarate dosage? A population pharmacokinetics analysis	26
Editorial: Honoring Prof. Gerhard Winter with the LMU Winter-Workshop special issue	26

Preclinical development of sodium fusidate antibiotic cutaneous spray based on water-free lipid formulation system	26
Intrinsic immunogenicity of liposomes for tuberculosis vaccines: Effect of cationic lipid and cholesterol	26
Development of inhalable extra-fine particles of vancomycin for the treatment of pulmonary methicillin-resistant Staphylococcus aureus infections	26
Contributions of intestine and liver to the absorption and disposition of FZJ-003, a selective JAK1 inhibitor with structure modification of filgotinib	26
Predicting mini-tablet dissolution performance utilizing X-ray computed tomography	25
Preincubation-dependent inhibition of organic anion transporting polypeptide 2B1	25
Injectable photo-crosslinked hyaluronic acid/carboxymethyl cellulose hydrogel for the sustained delivery of rhFGF2 and accelerated wound healing	25
Individualized dosing strategies in breast cancer chemotherapy: Evidence for therapeutic drug monitoring-guided docetaxel treatment	25
Blood-brain barrier permeability revisited: Predicting intrinsic passive BBB permeability using the Solubility-diffusion model	25
Enhancing spinal cord injury recovery with functional liposomal nanomedicine: A neuroprotective and anti-inflammatory approach	25
Psoriatic skin-sensitive degradable mesoporous zinc phosphate microsphere as a photosensitizer in photodynamic therapy for anti-psoriasis	25
Preparation and characterization of a secnidazole-mandelic acid coamorphous system: enhanced dissolution profile, antibacterial properties, and theoretical druglikeness assessment	25
ROS-responsive diselenide exosomes restore mitophagy to resolve sterile inflammation in liver IRI	25
In vivo antiseizure activity of triazolyl oxazolidinone derivatives in rats	24
PD-L1 downregulation by carbonic anhydrase IX immunotherapy prompts immune checkpoint blockade in renal cell carcinoma	24
Towards model-informed precision dosing of cyclosporine in adult renal transplantation: Assessing population pharmacokinetic models and multi-model strategies	24
Novel indole-based derivatives as promising NLRP3 inflammasome inhibitors: Design, synthesis, biological evaluation, and in silico studies	24
Small molecule drug absorption in inflammatory bowel disease and current implementation in physiologically- based pharmacokinetic models	24
Polymer Coated Polymeric (PCP) microneedles for sampling of drugs and biomarkers from tissues	23
The development and characterization of in vivo-like three-dimensional models of bronchial epithelial cell lines	23
Nanosuspensions technology as a master key for nature products drug delivery and In vivo fate	23
Harmonizing the craft of crafting clinically endorsed small-molecule BCR-ABL tyrosine kinase inhibitors for the treatment of hematological malignancies	23
Comparing the performance of electrostatic repulsion-reversed phase chromatography approaches in the resolution of complex peptide mixture: Liraglutide as case study	23
Development and validation of a semi-automated hybrid immunocapture liquid chromatography-mass spectrometry method to quantify LALA-mutated biotherapeutics in mouse plasma	23
Editorial Board	22
Transport across membrane meets biophysics to unveil the mechanism of action of a novel gH625 analogue	22
The impact of possible improper use on the performance in vitro of NEXThaler in comparison with Ellipta inhaler	22
Corrigendum to “ Small molecules modified mesoporous silica nanoparticles orally deliver indomethacin with synergistic effect” [European Journal of Pharmaceutical Sciences 195 (2024) 106719]	22
Repositioning gemigliptin for the alleviation of thioacetamide-induced liver fibrosis in rats: Targeting TLR4/MAPK, SIRT1/AMPK/Nrf2, PI3K/AKT/mTOR axis and apoptosis	22
The overview of development of novel bacterial topoisomerase inhibitors effective against multidrug-resistant bacteria in an academic environment: From early hits to in vivo active antibacterials	22
The influence of solvent composition and process parameters on the particle properties of phytosterols in batch cooling crystallization	21
Impact of surface energy and surface tension on vial fogging within lyophilized drug products	21
Modular self-emulsifying drug delivery platform to enhance cellular uptake activity in triple-negative breast cancer	21
Formulation and investigation of differently charged β-cyclodextrin-based meloxicam potassium containing nasal powders	21
Pharmacokinetic and gut microbiota analyses revealed the effect of Lactobacillus acidophilus on the metabolism of Olsalazine in ulcerative colitis rats	21
Absorption, distribution, metabolism, excretion and mass balance of ainuovirine, a non-nucleoside reverse transcriptase inhibitor in humans	20
High-performance liquid chromatography method for simultaneous determination of the degradation products of metformin hydrochloride and vildagliptin	20
Safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of a novel anti-TSLP bispecific antibody (GR2002) in healthy Chinese adults: A randomized, placebo-controlled phase 1 trial	20
Comparison of intravenous ibuprofen pharmacokinetics between Caucasian and Chinese populations using physiologically based pharmacokinetics modeling and simulation	20
Vitamin D loaded into lipid nanoparticles shows insulinotropic effect in INS-1E cells	20
Editorial Board	20
Dissolution changes in drug-amino acid/biotin co-amorphous systems: Decreased/increased dissolution during storage without recrystallization	20
Ex vivo diffusion and biodistribution studies of progesterone delivered to the eye using 3D-printed inserts	20
Modulation of FOXO3a Nuclear Localization by Linagliptin (BI-1356) reveals a new therapeutic target in chronic ulcerative colitis	19
Sex differences in suspected adverse drug reactions of anti-seizure medications reported in EudraVigilance	19
Characterization of digital camera-based UV illumination fluorescent imaging for concentration measurement with limit of detection, specificity and precision	19
Impact of shelf-life on the pharmaceutical equivalence assessment of a hydrocortisone semisolid W/O emulsion: Evaluation of rheological, structural, and release properties	19
Novel Coumarin-furo[2,3-d]pyrimidinone hybrid derivatives as anticancer agents: Synthesis, biological evaluation and molecular docking	19
Physiologically-based pharmacokinetic modeling to predict the exposure and provide dosage regimens of Ustekinumab in pediatric patients with inflammatory bowel disease	19
Preclinical validation of tetrahydroquinoline derivatives as EGFR inhibitor inducing glioblastoma cell death	19
Modeling the complexity of drug-drug interactions: A physiologically-based pharmacokinetic study of Lenvatinib with Schisantherin A/Schisandrin A	19
Ligand binding to proteins – When flawed fluorescence quenching methodology and interpretation become the new norm	19
A physiologically based biopharmaceutics modeling (PBBM) framework for characterizing formulation-dependent food effects: Paving the road towards fed state virtual BE studies for itraconazole amorphou	19
Corrigendum to “Optimization and aerodynamic performance of nebulizable pirfenidone-loaded human serum albumin nanoparticles for targeted pulmonary delivery” [European Journal of Pharmaceutical Scienc	19
Investigating the relevance of CYP2J2 inhibition for drugs known to cause intermediate to high risk torsades de pointes	19
Aerosolized sulfated hyaluronan derivatives prolong the survival of K18 ACE2 mice infected with a lethal dose of SARS-CoV-2	18
The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the fifth international EUFEPS/AAPS conference	18
In-situ investigation of solid phase evolution during lyophilization of mannitol-based antibody formulations using an XRPD climate chamber	18
Zeta potential shifting nanoemulsions comprising single and gemini tyrosine-based surfactants	18
Retraction notice to “Pharmacokinetics of free mycophenolic acid and limited sampling strategy for the estimation of area under the curve in liver transplant patients” [European Journal of Pharmaceuti	18
Human enteroid monolayers as a potential alternative for Ussing chamber and Caco-2 monolayers to study passive permeability and drug efflux	18
Drug-drug interactions and dose management of BTK inhibitors when initiating nirmatrelvir/ritonavir (paxlovid) based on physiologically-based pharmacokinetic models	18
Feasibility of disease terminology systems for mapping orphan conditions and therapeutic indications of designated orphan medicines in the European Union	18
Development and characterization of a spray-dried inhalable ternary combination for the treatment of Pseudomonas aeruginosa biofilm infection in cystic fibrosis	18
The allostery and modification of hGHRH molecules and specific dimer produced significant fertility effect by proliferating and activating in-situ ovarian mesenchymal stem cells	18
Preclinical safety assessment of holmium-based microspheres for micro-brachytherapy in mice	18
Menthol-based deep eutectic systems as antimicrobial and anti-inflammatory agents for wound healing	17
Spectral and mass characterization of kinetic conversion from retinoids to retinoic acid in an in vitro 3-D human skin equivalent model	17
Predicting the tabletability of binary powder mixtures from that of individual components	17
Empowering the pharmaceutical workforce for the digital future	17
The environmental burden of inhalation	17
CD44-targeted cyclodextrin-hyaluronic acid nanoparticles carrying gemcitabine and paclitaxel to pancreatic cancer	17
Multiphysics simulation of liposome release from hydrogels for cavity filling following patient-specific breast tumor surgery	17
Orally disintegrating drug carriers for paediatric pharmacotherapy	17
Personalized oral drug delivery via FDM 3D printing: Polyvinyl alcohol capsules with tunable release profiles supported by in silico modeling	17
Physiologically-based pharmacokinetic modeling to predict the exposure and to assess pharmacodynamics of daptomycin in infants within 1 year old	17
A comprehensively validated IVRT method reliably discriminates sameness and differences between several topical clotrimazole creams	17
Novel anti-psoriatic nanostructured lipid carriers for the cutaneous delivery of luteolin: A comprehensive in-vitro and in-vivo evaluation	17
Extending the limitations in the prediction of PAMPA permeability with machine learning algorithms	17
A novel microbubble delivery platform with high payload of paclitaxel upon focused ultrasound for enhanced glioblastoma treatment	17

In vivo evidence of functional OATP2B1 activity in human skeletal muscle using [11C]erlotinib PET	17
PL3 CendR peptide shows specific uptake in cultured Y79 retinoblastoma cells with nucleolar accumulation	17
The impact of advanced age on gastrointestinal characteristics that are relevant to oral drug absorption: An AGePOP review	17
Investigation of flurbiprofen pharmacokinetics in rats following dermal administration of optimized cyclodextrin-based nanogel	17
Rethinking of TEER measurement reporting for epithelial cells grown on permeable inserts	17
The ROC skin model: A robust skin equivalent for permeation and live cell imaging studies	16
Advances in understanding cisplatin-induced toxicity: Molecular mechanisms and protective strategies	16
Mechanistic insights into the effect of drug content on adhesive properties of transdermal patch containing lidocaine	16
Towards a gold standard functional readout to characterize In Vitro lung barriers	16
Editorial Board	16
Novel nanomicelle butenafine formulation for ocular drug delivery against fungal keratitis: In Vitro and In Vivo study	16
Thermosensitive in situ gels for ocular drug delivery: Advances in polymer-based formulations	16
Targeting the HSP90/miR-656 Axis to Suppress Lung Cancer Stem Cells and Overcome Autophagy-Mediated Drug Resistance in Non-Small Cell Lung Cancer	16
Metastasis and angiogenesis: preclinical PET study on hepatocellular carcinoma (He/De) tumor models	16
Analyzing parametric influences driving age-associated changes in absorption using a PBPK-GSA approach	15
Synthesis, in vitro characterization and biopharmaceutical evaluation of a novel phosphate prodrug of sorafenib	15
NDMA in macrolides: GC-MS/MS method for its detection and study of its formation	15
Advancing therapeutics with targeted formulations of hydrogen sulphide donors	15
Membrane interaction studies of isoniazid derivatives active against drug-resistant tuberculosis	15
Experimental and model-based approach to evaluate solvent effects on the solubility of the pharmaceutical artemisinin	15
Intratracheal instillation of chitosan-coated formononetin-loaded porous microspheres prolongs lung retention and improves the treatment in bleomycin-induced pulmonary fibrosis	15
Blood-brain Barrier Permeable and Multi-stimuli Responsive Nanoplatform for Orthotopic Glioma Inhibition by Synergistic Enhanced Chemo-/Chemodynamic/Photothermal/Starvation Therapy	15
Proteolysis Targeting Chimeras (PROTACs) based on celastrol induce multiple protein degradation for triple-negative breast cancer treatment	15
Stabilizing effect of HP-β-CD on infliximab in liquid formulations and a solid formulation produced by electrospinning	15
Electrospun poly(ester-carbonate)/poly(carbonate-urethane) membranes with controlled drug release for potential use in abdominal surgery	15
Cancer-type OATP1B3-V1 is a functional plasma membrane transporter mediating increased uptake of chemotherapeutics in vitro and in vivo	15
Retraction notice to “Amelioration of UV radiation-induced photoaging by a combinational sunscreen formulation via aversion of oxidative collagen degradation and promotion of TGF-β-Smad-mediated colla	15
Physiologically based pharmacokinetic modeling of brivaracetam and its interactions with rifampin based on CYP2C19 phenotypes	15
Intra-aortic infusion of nicotine can induce a novel mouse model of abdominal aortic aneurysm	14
Freeze-drying cycle optimization of an amorphous solid dispersion of resveratrol	14
Joint use of population pharmacokinetics and machine learning for prediction of valproic acid plasma concentration in elderly epileptic patients	14
Candesartan exhibits low intrinsic permeation capacity and affects buccal tissue viability and integrity: An ex vivo study in porcine buccal mucosa	14
Design and optimisation of phospholipid vesicles for topical betamethasone dipropionate	14
Real-life dosing conditions in older adults and geriatric patients in Poland – An international questionnaire study to investigate the regional differences in drug intake behaviour in the older popula	14
Implication of methylselenocysteine in combination chemotherapy with gemcitabine for improved anticancer efficacy	14
Investigation of the bactericidal mechanism of Penicilazaphilone C on Escherichia coli based on 4D label-free quantitative proteomic analysis	14
Applying exposure-response analysis to enhance Mycophenolate Mofetil dosing precision in pediatric patients with immune-mediated renal diseases by machine learning models	14
Tofersen in SOD1-associated amyotrophic lateral sclerosis: From molecular mechanisms to regulatory milestones	14
Predictive computational models for assessing the impact of co-milling on drug dissolution	14
Local delivery of lipid-based nanoparticles containing microbial nucleic acid for osteoimmunomodulation	14
Optimization and aerodynamic performance of nebulizable pirfenidone-loaded human serum albumin nanoparticles for targeted pulmonary delivery	14
Capsule-Based dry powder inhaler evaluation using CFD-DEM simulations and next generation impactor data	14
Influence of particle diameter on aerosolization performance and release of budesonide loaded mesoporous silica particles	14
Update on clinical trials of intra-articular disease-modifying osteoarthritis drugs inducing cartilage regeneration	13
Comparision of the phenol red, gravimetric, and synthesized mPEG-PR methods for correcting water flux using the single-pass intestinal perfusion method	13
Assessing the contribution of UGT isoforms on raltegravir drug disposition through PBPK modeling	13
The 8th International Symposium on Phospholipids in Pharmaceutical Research – An update on current research in phospholipids presented at the biennial symposium of the Phospholipid Research Center Hei	13
Secretion and surface display of binders of IL-23/IL-17 cytokines and their receptors in Lactococcus lactis as a therapeutic approach against inflammation	13
Transcutaneous amorphous preparation co-delivering curcumin and modified aptamer as a synergistic approach for the amelioration of psoriasis-like skin inflammation	13
TAT decorated siRNA polyplexes for inhalation delivery in anti-asthma therapy	13
Parameters to consider for successful medication use in older adults - An AGePOP review	13
Assessing the performance of new chromatographic technologies for the separation of peptide epimeric impurities: the case of Icatibant	13
Editorial Board	13
Design and development of microformulations for rapid release of small molecules and oligonucleotides	13
Editorial Board	13
Influence of P-glycoprotein on pulmonary disposition of the model substrate [11C]metoclopramide assessed by PET imaging in rats	13
Evaluating polymer influence on resuspendability of indomethacin suspensions produced by microfluidization	13
Kiwi-derived extracellular vesicles for oral delivery of sorafenib	13
Pulmonary delivery of siRNA lipoplexes and lipid nanoparticles using a vibrating mesh nebuliser	13
On the rheological and sensory properties of a novel natural salivary substitute	13
Enhancing drug release from PEG-PLGA implants: The role of Hydrophilic Dexamethasone Phosphate in modulating release kinetics and degradation behavior	13
Using molecularly dissolved drug concentrations in PBBMs improves the prediction of oral absorption from supersaturating formulations	13
A commentary on “Are all measures of liver Kpuu a function of F, as determined following oral dosing, or have we made a critical error in defining hepatic drug clearance?”	13
Editorial Board	13
Editorial Board	13
Thermosensitive smart hydrogel of PEITC ameliorates the therapeutic efficacy in rheumatoid arthritis	13
Population pharmacokinetics of cyclosporine A in hematopoietic stem cell transplant recipients: A systematic review	13
Enhancing Martini 3 for protein self-interaction simulations	12
Enhanced intracellular uptake of an albumin fusion protein in cancer cells by its forced cell surface recruitment	12
PRGF eye drops mitigate oxidative stress and fibrosis in an in vitro glaucoma model: The role of platelet and plasma enrichment	12
Selective Nanomolar Inhibitors of Carbonic Anhydrases IX and XII: Coumarin Aminophosphonates as Potential Anticancer Agents	12
Overcoming drug impurity challenges in amorphous solid dispersion with rational development of biorelevant dissolution-permeation method	12
Real-time component-based particle size measurement and dissolution prediction during continuous powder feeding using machine vision and artificial intelligence-based object detection	12
Direct immunomodulatory effects of DSPC:DSPG:CHOL liposomes on murine dendritic cells	12
Application of ionic liquid to enhance the nose-to-brain delivery of etodolac	12
Are all measures of liver Kp a function of F, as determined following oral dosing, or have we made a critical error in defining hepatic drug clearance?	12
Interaction of liposomes with bile salts investigated by asymmetric flow field-flow fractionation (AF4): A novel approach for stability assessment of oral drug carriers	12
Sodium-glucose co-transporter-2 inhibitors and epicardial adiposity	12
Developing an in vitro lipolysis model for real-time analysis of drug concentrations during digestion of lipid-based formulations	12
Cannabidiol—A friend or a foe?	12
J24335 exerts neuroprotective effects against 6-hydroxydopamine-induced lesions in PC12 cells and mice	12
Application of PBPK modeling in predicting maternal and fetal pharmacokinetics of levetiracetam during pregnancy	12
Enhanced nuclear enrichment of chemotherapeutics by a biomimetic ZIF-8 nanosystem for multidrug-resistant cancer treatment	12
Design, synthesis and bioevaluation of novel prenylated chalcones derivatives as potential antitumor agents	12
Preparation of nanoparticle and nanoemulsion formulations containing repaglinide and determination of pharmacokinetic parameters in rats	12
Development of novel montmorillonite-based sustained release system for oral bromopride delivery.	12
Excipient variability critically impacts crystallization propensity of spray-dried amorphous solid dispersions	12
Recent advances and clinical translation of liposomal delivery systems in cancer therapy	12
Dumping test: In vitro predictive tool for bioequivalence of Telmisartan formulations	12
Functional properties and molecular docking of different nanoparticles with ROS-sensitive phenylboronylated chitosan as the carrier	12
Embedding lipid nanodispersions in matrices: preparation of solid dosage forms with high lipid content and structural investigations using atomic force microscopy	11
Investigation into the impact of proton pump inhibitors on sertraline transport across the blood-brain barrier	11
Editorial: Biologically inspired engineering of the lungs: Advances in preclinical pulmonary pathobiology models for translational and therapeutic applications	11
Targeted blocking of EGFR and GLUT1 by compound H reveals a new strategy for treatment of triple-negative breast cancer and nasopharyngeal carcinoma	11
The potential use of tetracyclines in neurodegenerative diseases and the role of nano-based drug delivery systems	11